Cause-Specific Healthcare Costs Following Hospitalization for Heart Failure and Cost Offset with SGLT2 Inhibitor Therapy:
ABSTRACTBackgroundLittle is known regarding differences in cause-specific costs between HF with EF≤40% versus >40%, and potential cost implications of SGLT2i therapy.ObjectivesTo compare cause-spec…